Pharmaceutical intermediates
Orforglipron Intermediates
24 pharmaceutical intermediates for Orforglipron.
About Orforglipron
- Originator
- CHUGAI PHARMACEUTICAL CO., LTD.
Available intermediates
24 intermediates currently listed for Orforglipron. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| N-Boc-L-Alaninol | 79069-13-9 | / | / |
| (4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride | 2212021-40-2 | / | / |
| tert-buty1 (S)-3-amino-2-(4- fluoro-3,5- dimethylpheny1)-4- methyl-2,4,6,7-tetrahydro-5H-pyrazoloB ,3-c ]pyridine-5-carboxylate | 2212021-59-3 | / | / |
| (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate | 2212021-56-0 | / | / |
| 2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5- dimethylpheny1)-4,5,6,7-2H-Imidazol-2-one, 1-[(4S)-2- (4-fluoro-3,5-dimethylpheny1)-4,5,6,7-1H- indazol-5- yl)- 1,3-dihydro- | 2212022-56-3 | / | / |
| 5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- | 2212021-61-7 | / | / |
| H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- | 2212021-81-1 | / | / |
| 5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid | 2212021-83-3 | / | / |
| (R)-4-Benzyl-2-oxazolidinone | 102029-44-7 | / | / |
| 5-Bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | / | / |
| 5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid | 2212021-83-3 | / | / |
| 1-(4-fluoro-1-methyl-1H-indazole-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-3-yl)-1,3-dihydro-2H-imidazole-2-one hydrochloride | 3036782-75-6 | / | / |
| 3-(3-(4-fluoro-1-methyl-1H-indazole-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester | 3036782-74-5 | / | / |
| tert-butyl 2-(4-fluoro-3,5-dimethylphenyl)-3-(2-oxo-1H-imidazol-3-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate | 2212022-03-0 | / | / |
| tert-butyl 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate | 2212021-41-3 | / | / |
| 5-Bromoindole-2-carboxylic acid | 7254-19-5 | / | / |
| 5-bromo-N-methyl-N-phenyl-1H-indole-2-carboxamide | 2860499-50-7 | / | / |
| (S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide | 2212021-79-7 | / | / |
| 1-(cyanomethyl)-5-[(4S)-2,2-dimethyloxan-4-yl]-N-methyl-N-phenylindole-2-carboxamide | 2212021-80-0 | / | / |
| (E)-3-(2-(methyl(phenyl)carbamoyl)-1H-indol-5-yl)acrylic acid | 3047292-97-4 | / | / |
| (R,E)-N-methyl-5-(3-oxo-3-(2-oxo-4-phenyloxazolidin-3-yl)prop-1-en-1-yl)-N-phenyl-1H-indole-2-carboxamide | 3047293-00-2 | / | / |
| (S)-3-Aminobutanenitrile Hydrochloride | 1073666-54-2 | / | / |
| 5-Bromo-2-fluoro-m-xylene | 99725-44-7 | / | / |
| 1,3,2-Dioxathiolane, 4-Methyl-, 2,2-dioxide, (4R)- | 1006381-03-8 | / | / |
Other programs under O
Building toward Orforglipron?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →